Inactive Instrument

Highlights Actelion CBOE EUROPE EQUITIES

Equities

ATLN

CH0010532478

End-of-day quote CBOE EUROPE EQUITIES Other stock markets
- ^CHF	-

2017	Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake	RE
2017	Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	RE

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Spin off	14/17/14	FA
Actelion : shareholders back R&D spinoff, keep J&J deal on track	05/17/05	RE
Actelion : Syngenta takeovers set to shake up Swiss SMI index	31/17/31	RE
Actelion : J&J, Actelion approach Swiss takeover board over deal structure - paper	06/17/06	RE
Actelion : Sanofi's takeover talks with Actelion progressing - source	21/16/21	RE
Actelion : J&J raises Actelion takeover pressure with higher price - source	30/16/30	RE
Actelion : ambitious independent-minded CEO will drive up takeover price	28/16/28	RE
Abbott Laboratories : Johnson & Johnson approaches Actelion about takeover deal	26/16/26	RE
Abbott Laboratories : J&J makes takeover approach for Swiss drugmaker Actelion - Bloomberg	25/16/25	RE
Ex-dividend day	09/16/09	FA
AbbVie : Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta	04/15/04	RE
AbbVie : Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta	04/15/04	RE
Ex-dividend day	12/15/12	FA
Ex-dividend day	12/14/12	FA
More firms weigh IPOs as biotech fever reaches Europe	13/14/13	RE
Ex-dividend day	22/13/22	FA
Ex-dividend day	08/12/08	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer